Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways
Treatment of head and neck squamous cell carcinomas (HNSCC), the sixth most frequent cancer worldwide, remains challenging. miRNA dysregulation is closely linked to tumorigenesis and tumor progression, thus emerging as suitable targets for cancer treatment. Transcriptomic analysis of TCGA HNSCC data...
Main Authors: | Rocío Granda-Díaz, Lorea Manterola, Francisco Hermida-Prado, René Rodríguez, Laura Santos, Vanessa García-de-la-Fuente, María Teresa Fernández, M. Daniela Corte-Torres, Juan P. Rodrigo, Saúl Álvarez-Teijeiro, Charles H. Lawrie, Juana M. Garcia-Pedrero |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223003001 |
Similar Items
-
Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
by: Antonella Catalano, et al.
Published: (2021-04-01) -
The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
by: Thomas Kubin, et al.
Published: (2020-09-01) -
Dabrafenib Promotes Schwann Cell Differentiation by Inhibition of the MEK-ERK Pathway
by: Kyuhee Park, et al.
Published: (2021-04-01) -
Caspase 3‐specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress‐induced apoptosis
by: Hisashi Moriizumi, et al.
Published: (2023-04-01) -
Cefotetan-bound human RKIP involves in Ras/Raf1/MEK/ERK signaling pathway
by: Guo Chenyun, et al.
Published: (2022-12-01)